Kato Asuka, Yamauchi Toshimasa, Kadowaki Takashi
1Department of Health and Social Behavior, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan.
2Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan.
Diabetol Int. 2019 Dec 21;11(2):73-75. doi: 10.1007/s13340-019-00421-w. eCollection 2020 Apr.
In the past few years, diabetes-related stigma has rapidly gained attention around the world. Many studies, including our study, show that a diabetes population is globally impacted by disease-specific stigma across age, gender, educational levels, employment status, and race/ethnicity. However, it still remains unclear whether some of these socioeconomic factors are more influential in terms of the social vulnerability of the exposed individuals with type 2 diabetes. Understanding how diabetes-related stigma influences patients through these socioeconomic and racial/ethnic factors, and how these impacts vary according to different patient populations would help us gain a further understanding of diabetes-related stigma as a whole. Thus, most importantly, we should establish a comprehensive, coherent study design (e.g., cross-regional study, cross-national study), identify more vulnerable patient populations, and tackle diabetes-related stigma in collaborative efforts with patients, clinicians, researchers, academic societies, governments, and all involved parties around the globe.
在过去几年中，糖尿病相关的污名化在全球范围内迅速受到关注。包括我们的研究在内的许多研究表明，糖尿病患者群体在全球范围内受到特定疾病污名化的影响，涉及年龄、性别、教育水平、就业状况以及种族/民族等方面。然而，目前仍不清楚这些社会经济因素中的某些因素在2型糖尿病患者的社会脆弱性方面是否更具影响力。了解糖尿病相关污名化如何通过这些社会经济和种族/民族因素影响患者，以及这些影响如何因不同患者群体而有所不同，将有助于我们更全面地理解糖尿病相关污名化。因此，最重要的是，我们应建立一个全面、连贯的研究设计（例如跨区域研究、跨国研究），识别更脆弱的患者群体，并与患者、临床医生、研究人员、学术团体、政府以及全球所有相关方共同努力应对糖尿病相关的污名化问题。
